Health TrialsbyHealthPanel

Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

This study will collect sensor data in subjects with T1D or T2D, 2-80 years of age.

Participants needed: 1,500
Trial details
Age: 2-80Biological sex: AllType: InterventionalSponsor: Medtronic MiniMed, Inc.Updated: Oct 7, 2026Locations: 18
Eligibility criteria

Age 2-80 years at time of screening. [+10]

Unable to consent due to a mental or intellectual disability. [+25]

Read more
Status: Recruiting

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

The purpose of this study is to evaluate the clinical performance of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in adult patients with Type 1 diabetes mellitus that cannot be controlled with subcutaneous insulin therapy (including external pump), and presenting with frequent, otherwise unexplained severe hyper- and/or hypoglycemia.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medtronic MiniMed, Inc.Updated: Sep 22, 2026Locations: 11
Eligibility criteria

Subject is aged ≥ 18 years old. [+5]

Subject is actively participating in an investigational study (drug or device) w... [+15]

Read more
Status: Recruiting

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

This study will demonstrate the safety and performance of the Novel Medtronic Experimental Automated Insulin Delivery system named MiniMed™ NMX8 system in people living with insulin-requiring diabetes in comparison with the MiniMed™ 780G system.

Participants needed: 116
Trial details
Age: 2+Biological sex: AllType: InterventionalSponsor: Medtronic MiniMed, Inc.Updated: Sep 21, 2026Locations: 9
Eligibility criteria

Is aged ≥2 years old at time of screening. [+10]

Has Addison's disease, growth hormone deficiency, hypopituitarism or definite ga... [+15]

Read more
Status: Not yet recruiting

Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes

The purpose of the study is to evaluate the safety and the effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery system, named MiniMed NMX8 system (referred also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes not achieving target clinical outcomes.

Participants needed: 230
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Medtronic MiniMed, Inc.Updated: Apr 28, 2026Locations: 21
Eligibility criteria

Is aged ≥ 18 years old at time of screening. [+9]

Has untreated Addison's disease, thyroid disorder, growth hormone deficiency, hy... [+14]

Read more